Miller unleashes new ads over the weekend that continue to take direct shots at A-B. Plus, three-tier takes a beating in Maryland as liquor chain gets victory.

Coors will enter the premium low carb market with a new brand, Coors Edge, to be tested in Dallas/Fort Worth.

As the Costco case heats up, NBWA steps up to the plate. Plus, more on the Harbin drama.

Albertson’s takes a page from the Wal-Mart playbook. Plus, is Miller running out of capacity? It’s a good problem to have, but not a good problem if you’re Pabst. And an update on the Harbin battle.

Is it spirits? Is it high gas prices? We look at the possible reasons why beer sales are sluggish, if they are indeed sluggish.

As A-B makes another big move in China, we wonder how if SABMiller and A-B will partner. Plus, March sales strong.

Final arguments were heard by a judge in NYC on the InterbrewAmbev/Femsa dispute over how the deal should go down, and a surprise revelation. Plus, is A-B on the right trail?

A-B posted strong earnings and STR growth for the first quarter. And pricing/mix is as strong as ever. But how will it deal with low carb threat?

The following is the actual text of A-B’s Q1 2004 earnings release

Boston volumes struggle against Sam Light comps, Interbrew posts strong US volumes, and LUSA may be the jilted bride left at the altar in the InterbrewAmbev deal.

The NBWA/Brewers Joint Legislative Conference is under way, and we’ve got a lot to talk about.

A-B steps up to the plate and defends the entire industry against an error and a misconception about beer bellies, carbs, sugars, and insulin. Is A-B being altruistic?

The Coors story remains similar to previous quarters: profits grow, US case sales down. Here are the details of Coors Q1 peformance.

The following is the actual press release announcing Coors Q1 2004 results.

LUSA gets momentum on a few of its brands. Plus, BI responds to CAMY, and Minn gets franchise protections, and Levy says we had a dry March.